| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,840,401 | 721,965 | 585,177 | 510,084 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 1,840,401 | 721,965 | 585,177 | 510,084 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 555,164 | 576,161 | 556,843 | 630,695 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,145,019 | 113,648 | 54,591 | 39,331 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 140,218 | 32,156 | (26,257) | (159,942) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 140,218 | 32,156 | (26,257) | (159,942) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 140,218 | 32,156 | (26,257) | (159,942) | | Income Tax Expense | 49,461 | 10,021 | (10,344) | (59,934) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 90,757 | 22,135 | (15,913) | (100,008) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 90,757 | 22,135 | (15,913) | (100,008) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $90,757 | $22,135 | ($15,913) | ($100,008) |
|
0.51% Nasdaq 0.00%
Income Statement
